126 related articles for article (PubMed ID: 21846186)
1. A112, a tamibarotene dimethylaminoethyl ester, may inhibit human leukemia cell growth more potently than tamibarotene.
Yuan C; Zhang YS; Cheng YN; Xue X; Xu WF; Qu XJ
Leuk Lymphoma; 2012 Feb; 53(2):295-304. PubMed ID: 21846186
[TBL] [Abstract][Full Text] [Related]
2. All-trans retinoic acid and a novel synthetic retinoid tamibarotene (Am80) differentially regulate CD38 expression in human leukemia HL-60 cells: possible involvement of protein kinase C-delta.
Uruno A; Noguchi N; Matsuda K; Nata K; Yoshikawa T; Chikamatsu Y; Kagechika H; Harigae H; Ito S; Okamoto H; Sugawara A
J Leukoc Biol; 2011 Aug; 90(2):235-47. PubMed ID: 21393419
[TBL] [Abstract][Full Text] [Related]
3. Tamibarotene.
Miwako I; Kagechika H
Drugs Today (Barc); 2007 Aug; 43(8):563-8. PubMed ID: 17925887
[TBL] [Abstract][Full Text] [Related]
4. Baicalin is a major component of PC-SPES which inhibits the proliferation of human cancer cells via apoptosis and cell cycle arrest.
Ikezoe T; Chen SS; Heber D; Taguchi H; Koeffler HP
Prostate; 2001 Dec; 49(4):285-92. PubMed ID: 11746275
[TBL] [Abstract][Full Text] [Related]
5. Salinomycin induces apoptosis and differentiation in human acute promyelocytic leukemia cells.
Zhao Y; Zhong L; Liu L; Yao SF; Chen M; Li LW; Shan ZL; Xiao CL; Gan LG; Xu T; Liu BZ
Oncol Rep; 2018 Aug; 40(2):877-886. PubMed ID: 29989650
[TBL] [Abstract][Full Text] [Related]
6. Fucoidan Suppresses the Growth of Human Acute Promyelocytic Leukemia Cells In Vitro and In Vivo.
Atashrazm F; Lowenthal RM; Woods GM; Holloway AF; Karpiniec SS; Dickinson JL
J Cell Physiol; 2016 Mar; 231(3):688-97. PubMed ID: 26241708
[TBL] [Abstract][Full Text] [Related]
7. Retinoid-dependent growth inhibition, differentiation and apoptosis in acute promyelocytic leukemia cells. Expression and activation of caspases.
Gianni M; Ponzanelli I; Mologni L; Reichert U; Rambaldi A; Terao M; Garattini E
Cell Death Differ; 2000 May; 7(5):447-60. PubMed ID: 10800078
[TBL] [Abstract][Full Text] [Related]
8. Blockade of mTOR signaling potentiates the ability of histone deacetylase inhibitor to induce growth arrest and differentiation of acute myelogenous leukemia cells.
Nishioka C; Ikezoe T; Yang J; Koeffler HP; Yokoyama A
Leukemia; 2008 Dec; 22(12):2159-68. PubMed ID: 18784743
[TBL] [Abstract][Full Text] [Related]
9. Restoration of CCAAT enhancer binding protein α P42 induces myeloid differentiation and overcomes all-trans retinoic acid resistance in human acute promyelocytic leukemia NB4-R1 cells.
Wang L; Xiao H; Zhang X; Liao W; Fu S; Huang H
Int J Oncol; 2015 Nov; 47(5):1685-95. PubMed ID: 26397153
[TBL] [Abstract][Full Text] [Related]
10. Preparation and antitumor activity of a tamibarotene-furoxan derivative.
Wang XJ; Duan Y; Li ZT; Feng JH; Pan XP; Zhang XR; Shi LH; Zhang T
Asian Pac J Cancer Prev; 2014; 15(15):6343-7. PubMed ID: 25124622
[TBL] [Abstract][Full Text] [Related]
11. Tamibarotene in patients with acute promyelocytic leukaemia relapsing after treatment with all-trans retinoic acid and arsenic trioxide.
Sanford D; Lo-Coco F; Sanz MA; Di Bona E; Coutre S; Altman JK; Wetzler M; Allen SL; Ravandi F; Kantarjian H; Cortes JE
Br J Haematol; 2015 Nov; 171(4):471-7. PubMed ID: 26205361
[TBL] [Abstract][Full Text] [Related]
12. Novel dichlorophenyl urea compounds inhibit proliferation of human leukemia HL-60 cells by inducing cell cycle arrest, differentiation and apoptosis.
Figarola JL; Weng Y; Lincoln C; Horne D; Rahbar S
Invest New Drugs; 2012 Aug; 30(4):1413-25. PubMed ID: 21728022
[TBL] [Abstract][Full Text] [Related]
13. RARalpha is a regulatory factor for Am-80-induced cell growth inhibition of hematologic malignant cells.
Jimi S; Mashima K; Matsumoto T; Hara S; Suzumiya J; Tamura K
Int J Oncol; 2007 Aug; 31(2):397-404. PubMed ID: 17611697
[TBL] [Abstract][Full Text] [Related]
14. PC-SPES decreases proliferation and induces differentiation and apoptosis of human acute myeloid leukemia cells.
Ikezoe T; Chen S; Saito T; Asou H; Kyo T; Tanosaki S; Heber D; Taguchi H; Koeffler HP
Int J Oncol; 2003 Oct; 23(4):1203-11. PubMed ID: 12964005
[TBL] [Abstract][Full Text] [Related]
15. A novel retinoic/butyric hyaluronan ester for the treatment of acute promyelocytic leukemia: preliminary preclinical results.
Coradini D; Pellizzaro C; Scarlata I; Zorzet S; Garrovo C; Abolafio G; Speranza A; Fedeli M; Cantoni S; Sava G; Daidone MG; Perbellini A
Leukemia; 2006 May; 20(5):785-92. PubMed ID: 16525489
[TBL] [Abstract][Full Text] [Related]
16. Promyelocytic leukemia retinoid signaling targets regulate apoptosis,tissue factor and thrombomodulin expression.
López-Pedrera C; Barbarroja N; Buendía P; Torres A; Dorado G; Velasco F
Haematologica; 2004 Mar; 89(3):286-95. PubMed ID: 15020266
[TBL] [Abstract][Full Text] [Related]
17. Novel antileukemic agents derived from tamibarotene and nitric oxide donors.
Bian H; Feng J; Li M; Xu W
Bioorg Med Chem Lett; 2011 Dec; 21(23):7025-9. PubMed ID: 22014829
[TBL] [Abstract][Full Text] [Related]
18. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
[TBL] [Abstract][Full Text] [Related]
19. Design and stereoselective synthesis of retinoids with ferrocene or N-butylcarbazole pharmacophores that induce post-differentiation apoptosis in acute promyelocytic leukemia cells.
Ivanova D; Gronemeyer H; de Lera AR
ChemMedChem; 2011 Aug; 6(8):1518-29. PubMed ID: 21506276
[TBL] [Abstract][Full Text] [Related]
20. Tamibarotene: AM 80, retinobenzoic acid, Tamibaro.
Drugs R D; 2004; 5(6):359-62. PubMed ID: 15563242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
